Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Solid Tumor × Sirolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor 1 Kidney Transplantation 1 Advanced HR - Positive, HER2 - Negative Breast Cancer 1

Interventions

Fluorodeoxyglucose F18 4 Drug Therapy 2 nimotuzumab 1 apatinib 1 Ultrasonography, Doppler 1 Ultrasonography 1 Sirolimus 1 Re-Irradiation 1 Radiosurgery 1 RE1-silencing transcription factor 1 Proton Therapy 1 Ink 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02449564 2018-01-17

The Pilot Study Evaluate the Safety and Efficacy of Sirolimus in Patients With PIK3CA Mutation and/or PIK3CA Amplification Refractory Solid Tumors

Samsung Medical Center

Phase NA Completed

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡